Clinical Trials Directory

Trials / Completed

CompletedNCT02321969

Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
176 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Experimental studies have shown the chemopreventive properties of green tea extract (GTE) on colorectal cancer. And colorectal adenomas are precursors to colorectal cancers. The aim of this study is to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by giving GTE tablets of which are equivalent of 9 cup-of-green tea per day (0.9 g/day GTE, 0.6 g/day Epigallocatechin gallate (EGCG).

Detailed description

The subjects who had undergone complete removal of colorectal adenomas by endoscopic polypectomy have been enrolled since June 2010. They were then randomized into two groups as follows: supplementation group (0.9 g GTE per day for 12 months) or control group without GTE supplementation. Follow-up colonoscopy was conducted in 12 months. A structured 72-h recall at baseline and the 1-year follow-up was used to assess dietary factors, and to evaluate rectal mucosal proliferation index (RMPI) using known proliferation markers (Ki-67/PCNA), at least 2 random biopsies of rectal mucosa were taken. A sample size of 176 patients (88 per each group) was calculated to give the study 80% power to detect a difference, assuming a two-sided significance test at the 0.05 level.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGTE (green tea extract)6 GTE tablets per day. Daily dose is equivalent of 9 cup-of-green tea per day (0.9 g/day GTE, 0.6 g/day epigallocatechin gallate \[EGCG\]).

Timeline

Start date
2010-08-01
Primary completion
2015-05-01
Completion
2015-10-01
First posted
2014-12-22
Last updated
2015-10-28

Source: ClinicalTrials.gov record NCT02321969. Inclusion in this directory is not an endorsement.